A contrary view: I would prefer for management to not buy shares now. Why? Because they can only buy shares if nothing is happening behind the scenes that would be material to the value of the shares. For example, during the drawn-out Biovail negotiations, they knew details of the transaction under discussion that would have made a stock purchase illegal. So I would still prefer that they not buy shares, because it at least leaves open the possibility that they are aware of something pertaining to the SA trial, or the sz/dep rights held by Merck, or something else entirely---that we don't know about. If they buy, it means nothing material is currently in play.
NeuroInvestment